The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 17, 2023
Filed:
May. 31, 2019
Applicant:
Lamkap Bio Beta Ltd., Schwyz Pfäffikon, CH;
Inventors:
Vanessa Buatois, Contamine-Sarzin, FR;
Stefano Majocchi, Grand Lancy, CH;
Klaus Strein, Weinheim, DE;
Assignee:
LamKap Bio beta Ltd., Schwyz Pfäffikon, CH;
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C12N 15/85 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); C07K 16/2809 (2013.01); C07K 16/3007 (2013.01); C12N 15/85 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/41 (2013.01); C07K 2317/52 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C12N 2015/8518 (2013.01);
Abstract
The invention provides bispecific antibodies binding to human carcinoembryonic antigen CEACAM5 and human CD47, polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further provides methods for selecting and producing such antibodies and methods of using such antibodies in the treatment of diseases in monotherapy as well in combination.